| BCA | Bicinchoninic Acid Assay |
| CDAP | 1-cyano-4-dimethylaminopyridinium tetrafluoroborate |
| CPS | Capsular polysaccharide |
| EDC | 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) |
| EOD | Early Onset Disease |
| GBS | Group B Streptococcus |
| GMC(s) | Geometric Mean concentration(s) |
| HZ-PEG-HZ | Hydrazide-Polyethylene Glycol-Hydrazide |
| IAP | Intrapartum Antibiotic Prophylaxis |
| IgG | Immunoglobulin G |
| LOD | Late Onset Disease |
| LMICs | Low- and Middle-Income Countries |
| MBIA | Multiplexed Bead-based Immunoassay |
| MNT | Maternal and Neonatal Tetanus |
| NZW | New Zealand White |
| OPA | Opsonophagocytic Killing Assay |
| PS | Polysaccharide |
| rCRM197 | recombinant Cross-Reacting Material197 |
| SEC-MALLS | Size Exclusion Chromatography Multi Angle Laser Light Scattering |
| ST | Serotype |
| SToRR | Serological Thresholds of Risk Reduction |
| TMP | Trans Membrane Pressure |
| TNBS | 2,4,6-trinitrobenzene sulfonic acid |